# Ondansetron

NDC: 68083-113
Generic name: Ondansetron
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20090925

FDA application: ANDA079224

## Active ingredients

- ONDANSETRON HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-113"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-113
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3efa5604-96c3-42a0-8e99-b3de4a66aa92